Skip to content

Mindfulness as a way to cope with COVID‐19‐related stress and anxiety

Robert Weis, Sullivan D. Ray, Tema A. Cohen

December 13, 2020 DOI: 10.1002/capr.12375 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial
Population College students
Intervention Koru Mindfulness
Duration Four-week intervention
Topics Anxiety Meditation
Keywords Education
Key findings Koru Mindfulness improved mindfulness, self-compassion, and attention, and reduced stress, anxiety, and sleep problems in college students during the COVID-19 pandemic.

Abstract

Abstract COVID-19 brought significant challenges to college students in Spring 2020 Mindfulness-based interventions might help students cope with COVID-19-related stressors in at least three ways: by cultivating attention that is self-directed rather than reactive to a rapidly changing situation;by teaching the acceptance and regulation of negative thoughts and feelings;and by encouraging individuals to view adverse events non-judgementally and as opportunities for growth The purpose of our study was to determine whether Koru Mindfulness (KM), a four-week, mindfulness-based group therapy designed for emerging adults, could help students cope with COVID-19-related stress and anxiety Students were assigned to either KM or waitlist at the beginning of the 2020 Spring semester Assessment of students? functioning occurred at baseline before the onset of COVID-19, mid-semester at the height of the COVID-19 crisis on campus, and the end of the semester after students had returned home and transitioned to remote learning After treatment, KM participants reported greater mindfulness and self-compassion and less stress, anxiety and sleep problems than controls KM participants also showed superior functioning on performance-based measures of attention Most gains were maintained over time Increased mindfulness mediated the relationship between KM and reductions in stress and anxiety KM can help students cope with academic and COVID-19-related stressors by improving mindfulness

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Citations in the library

Cited by 18

and 13 more in the library

Cites 9

and 4 more in the library

Explore topics